Telitacicept 
RemeGen
['lupus', 'telitacicept']
congress #eular2023 | ronald van vollenhoven, , presented phase iii data from study of novel blys/april inhibitor telitacicept vs pbo in 335 pts with #sle. 67.1% of telitacicept pts achieved sri-4 at week 52. there were less saes in telitacicept group vs pbo. #lupus 
An online resource, dedicated to providing information and up-to-date medical education within the lupus space.